Search by Drug Name or NDC

    NDC 55154-4322-00 POSACONAZOLE 100 mg/1 Details

    POSACONAZOLE 100 mg/1

    POSACONAZOLE is a ORAL TABLET, DELAYED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Cardinal Health 107, LLC. The primary component is POSACONAZOLE.

    Product Information

    NDC 55154-4322
    Product ID 55154-4322_111ab7c6-b0c3-4d15-9f40-6c03d3d16bc2
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name POSACONAZOLE
    Proprietary Name Suffix n/a
    Non-Proprietary Name POSACONAZOLE
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, DELAYED RELEASE
    Route ORAL
    Active Ingredient Strength 100
    Active Ingredient Units mg/1
    Substance Name POSACONAZOLE
    Labeler Name Cardinal Health 107, LLC
    Pharmaceutical Class Azole Antifungal [EPC], Azoles [CS]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA213454
    Listing Certified Through 2024-12-31

    Package

    NDC 55154-4322-00 (55154432200)

    NDC Package Code 55154-4322-0
    Billing NDC 55154432200
    Package 10 BLISTER PACK in 1 BAG (55154-4322-0) / 1 TABLET, DELAYED RELEASE in 1 BLISTER PACK
    Marketing Start Date 2023-08-01
    NDC Exclude Flag N
    Pricing Information N/A